Slide 1: Dorai by Date: Dorai Ramjee Ramjee 2020.07.31
Digitally signed Dorai byDate:Dorai Ramjee Ramjee 2020.07.31 19:36:52 +05'30'
Slide 2: Disclaimer
Thyrocare Technologies Limited Presentation – Q12021 Disclaimer This presentation is for information purposes only and it contains general background information about the Company’s activities. The Company assumes no responsibility to publicly amend, modify or revise any forward looking statements o
Slide 3: Impact of coronavirus [COVID-19]
Impact of coronavirus [COVID-19] The novel coronavirus [COVID-19] pandemic is spreading around the globe rapidly. The virus has taken its toll on not just human life, but business and financial markets too, the extent of which is currently indeterminate. While the outbreak has had an impact on almos
Slide 4: Quarterly financial Performance - Thyrocare
Quarterly financial Performance - Thyrocare Thyrocare Technologies Limited Thyrocare Technologies Limited Statement of Unaudited Standalone Financial Results (Rs. in crore, except per share data) Balance sheet data Particulars 3 months ended Particulars June 30, June 30, 2020 2019 June 30, % June 30
Slide 5: Quarterly performance updates - Thyrocare
Quarterly performance updates - Thyrocare Key Updates Non-Covid Revenue got severally impacted, particularly in the month of April 2020, due to lockdown and restriction on movement imposed. The Non-Covid revenue however was marginally revived in the month of May 2020 and further improved in the mo
Slide 6: Quarterly financial Performance - Nueclear
Quarterly financial Performance - Nueclear Nueclear Healthcare Limited Nueclear Healthcare Limited Statement of Unaudited Standalone Financial Results (Rs. in crore, except per share data) Balance sheet data Particulars 3 months ended Particulars June 30, June 30, 2020 2019 June 30, % June 30, % 202
Slide 7: Quarterly performance updates - Nueclear
Quarterly performance updates - Nueclear Key Updates Nueclear business got severally impacted, particularly in the month of April 2020, due to lockdown and restriction on movement imposed. The operations were completely suspended at Delhi, Hyderabad, Bangalore and Coimbatore due to non availabilit
Slide 8: Quarterly consolidated financial Performance - Thyrocare
Quarterly consolidated financial Performance - Thyrocare Thyrocare Technologies Limited [Consolidated] Thyrocare Technologies Limited [Consolidated] Statement of Unaudited Standalone Financial Results (Rs. in crore, except per share data) Balance sheet data Particulars 3 months ended Particulars Jun
Slide 9: Consolidated performance updates - Thyrocare
Quarterly consolidated performance updates - Thyrocare Key Updates Non-Covid Revenue and Imaging Revenue got severally impacted, due to lockdown and restriction on movement imposed. The Non-Covid revenue however was marginally revived in the month of May 2020 and further improved in the month of J
Slide 10: Thank You
Thyrocare’ The Trust. The Truth. THANK YOU